Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (151-160 of 499) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patientsJeroen Dekervel, Daphne Hompes, Hannah van Malenstein, et al.
Clinical Colorectal Cancer|January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT TrialJulien Taieb, Marwan Fakih, Josep Tabernero, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Radiation Oncology (London, England)|September 24, 2008
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinomaTom Budiharto, Karin Haustermans, Eric Van Cutsem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
A Multicenter Phase II Study of AMG 337 in Patients with <i>MET</i>-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other <i>MET</i>-Amplified Solid TumorsEric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, et al.
Clinical Colorectal Cancer|January 10, 2025
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal CancerCharlotte Claeys, Antoon Billiet, Karin Haustermans, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2013
European experts consensus statement on cystic tumours of the pancreasMarco Del Chiaro, Caroline Verbeke, Roberto Salvia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2013
Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: results from the expansion cohort of a phase I studyDavid Khayat, Sabine Tejpar, Jean-Philippe Spano, et al.
Pageof 50

Showing results (151-160 of 499) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patientsJeroen Dekervel, Daphne Hompes, Hannah van Malenstein, et al.
Clinical Colorectal Cancer|January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT TrialJulien Taieb, Marwan Fakih, Josep Tabernero, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Radiation Oncology (London, England)|September 24, 2008
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinomaTom Budiharto, Karin Haustermans, Eric Van Cutsem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
A Multicenter Phase II Study of AMG 337 in Patients with <i>MET</i>-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other <i>MET</i>-Amplified Solid TumorsEric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, et al.
Clinical Colorectal Cancer|January 10, 2025
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal CancerCharlotte Claeys, Antoon Billiet, Karin Haustermans, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2013
European experts consensus statement on cystic tumours of the pancreasMarco Del Chiaro, Caroline Verbeke, Roberto Salvia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2013
Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: results from the expansion cohort of a phase I studyDavid Khayat, Sabine Tejpar, Jean-Philippe Spano, et al.
Pageof 50